Evidence map›Paper›PMID 37494104›Full record

ArticleEuropean journal of neurology2023

How to distinguish Guillain-Barré syndrome from nitrous oxide-induced neuropathy: A 2-year, multicentric, retrospective study.

Etienne Fortanier, Edouard Berling, Adrien Zanin, Adrien Le Guillou, Joelle Micaleff, Guillaume Nicolas, Pierre Lozeron, Shahram Attarian

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Etienne FortanierReference Center for Neuromuscular Diseases and ALS, La Timone University Hospital, Aix-Marseille University, Marseille, France.ORCID 0000-0003-2797-9389
Edouard BerlingAPHP, Service de Neurologie, Hôpital Raymond Poincaré, Centre de référence Nord-Est-Ile-de-France, FHU PHENIX, Garches, France.
Adrien ZaninService de Physiologie Clinique-Explorations Fonctionnelles, DMU DREAM, APHP, Hôpital Lariboisière, Paris, France.
Adrien Le GuillouDepartment of Epidemiology, Emory University, Atlanta, Georgia, USA.
Joelle MicaleffMarseille University Hospital, Clinical Pharmacology and Pharmacosurveillance, Regional Addictovigilance Center of Marseille, Marseille, France.
Guillaume NicolasAPHP, Service de Neurologie, Hôpital Raymond Poincaré, Centre de référence Nord-Est-Ile-de-France, FHU PHENIX, Garches, France.
Pierre LozeronService de Physiologie Clinique-Explorations Fonctionnelles, DMU DREAM, APHP, Hôpital Lariboisière, Paris, France.ORCID 0000-0003-1185-9307
Shahram AttarianReference Center for Neuromuscular Diseases and ALS, La Timone University Hospital, Aix-Marseille University, Marseille, France.
Inserm · FRAix-Marseille Université · FREmory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecreational use of nitrous oxide (N

methodsFifty-eight N

resultsThe typical N

conclusionsVitamin B12 serum level < 200 pmol/L cut-off and conduction blocks in initial electrophysiological study are the two most sensitive biomarkers for rapidly distinguishing N

Indexed as

Guillain-Barre SyndromeBiomarkersHumansNitrous OxideRetrospective StudiesVitamin B 12BiomarkersNitrous OxideVitamin B 12Guillain-BarréN2Oneuropathynitrous oxidetoxic

Identifiers

PMID37494104
OpenAlexW4385262431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.